Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NeuVax + Herceptin in HER2-low/intermediate breast cancer
NCT01570036Phase 2Completed
- Start
- May 2013
- Primary completion
- Sep 2018
- Modality
- Peptides, Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
A Phase 2 trial of nelipepimut-S in breast cancer. Started May 2013; status: completed.
02
Drugs
nelipepimut-S
03
Conditions
breast cancer
Beyond the preview
Go deeper on NCT01570036.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01570036.